Peregrine Capital Management LLC Bluebird Bio, Inc. Transaction History

Peregrine Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$27.5 - $37.92 $2.17 Million - $2.99 Million	-78,977 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$34.44 - $43.75 $259,402 - $329,525	-7,532 Reduced 8.71%	78,977 $2.76 Million
Q2 2020 Jul 30, 2020	SELL	$27.12 - $45.97 $1.25 Million - $2.13 Million	-46,245 Reduced 34.84%	86,509 $3.42 Million
Q1 2020 Apr 17, 2020	BUY	$26.16 - $63.5 $10,123 - $24,574	387 Added 0.29%	132,754 $3.95 Million
Q4 2019 Jan 16, 2020	BUY	$46.96 - $61.67 $730,791 - $959,708	15,562 Added 13.32%	132,367 $7.52 Million
Q3 2019 Oct 16, 2019	BUY	$59.47 - $93.1 $6.95 Million - $10.9 Million	116,805 New	116,805 $6.95 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.